Related Experiment Video
Updated: Oct 30, 2025
11:18
Direct Drug Delivery to Kidney via the Renal Artery
Published on: April 17, 2021
7.8K
The Danish Network for Community Pharmacy Practice Research and Development.
Alaa Burghle1,2, Rikke Nørgaard Hansen3, Lotte Stig Nørgaard4
1Hospital Pharmacy Funen, Odense University Hospital, 5000 Odense, Denmark.
Pharmacy (Basel, Switzerland)
|July 2, 2021
Summary
Community pharmacies are ideal for research due to accessibility and patient volume. The Danish Network for Community Pharmacy Practice for Research and Development (NUAP) was formed to enhance pharmacy practice and research through collaboration.
Area of Science:
- Pharmacy Practice Research
- Health Services Research
Background:
- Community pharmacies offer high patient accessibility and a large patient turnover, ideal for data collection.
- Nationwide research in community pharmacies can be time-consuming, necessitating collaborative networks.
- The Danish Network for Community Pharmacy Practice for Research and Development (NUAP) was established to address these challenges.
Purpose of the Study:
- To establish a collaborative network for community pharmacy practice and research in Denmark.
- To strengthen pharmacy practice and research through the joint efforts of practitioners and researchers.
- To provide a forum for meeting and collaboration between community pharmacy practitioners and researchers.
Main Methods:
- Formation of the Danish Network for Community Pharmacy Practice for Research and Development (NUAP).
- Inclusion of 102 community pharmacy owners and researchers as members.
- Governance by a steering committee elected by network members.
Main Results:
- NUAP serves as a collaborative platform connecting community pharmacies and researchers.
- The network facilitates the development and implementation of pharmacy practice research.
- Membership comprises a significant portion of Danish community pharmacy owners and associated researchers.
Conclusions:
- Collaborative networks are essential for effective and efficient community pharmacy research.
- NUAP strengthens pharmacy practice and research capacity in Denmark.
- The network model promotes knowledge exchange and innovation in community pharmacy settings.
More Related Videos
07:02A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
Published on: February 11, 2019
10.0K
09:39A Platform of Anti-biofilm Assays Suited to the Exploration of Natural Compound Libraries
Published on: December 27, 2016
18.1K
Related Concept Videos
01:19Pharmacovigilance
1.3K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.3K
01:26Therapeutic Drug Monitoring: Drug Analysis Methods
36
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
36
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
40
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
40
01:28Preclinical Development: Overview
5.3K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.3K
01:16Clinical Trials
9.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
9.9K
01:12Analysis of Population Pharmacokinetic Data
479
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
479